Docusign Inc. (NASDAQ:DOCU – Get Free Report) Director Teresa Briggs sold 365 shares of Docusign stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $50.04, for a total value of $18,264.60. Following the completion of the transaction, the director directly owned 10,263 shares in the company, valued at $513,560.52. This trade represents a 3.43% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Docusign Price Performance
Shares of Docusign stock opened at $50.94 on Friday. The business’s 50 day simple moving average is $47.74 and its two-hundred day simple moving average is $54.21. The stock has a market capitalization of $9.90 billion, a P/E ratio of 34.42, a price-to-earnings-growth ratio of 2.00 and a beta of 0.92. Docusign Inc. has a one year low of $40.16 and a one year high of $94.67.
Docusign (NASDAQ:DOCU – Get Free Report) last announced its quarterly earnings results on Thursday, June 4th. The company reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. The business had revenue of $830.24 million for the quarter, compared to analysts’ expectations of $824.71 million. Docusign had a return on equity of 16.86% and a net margin of 9.60%.The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.90 EPS. Sell-side analysts expect that Docusign Inc. will post 1.76 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
DOCU has been the topic of a number of analyst reports. BTIG Research reaffirmed a “buy” rating and issued a $70.00 price target on shares of Docusign in a research note on Wednesday, March 18th. Citizens Jmp decreased their price target on Docusign from $124.00 to $86.00 and set a “market outperform” rating on the stock in a research note on Wednesday, March 18th. Bank of America initiated coverage on Docusign in a research note on Tuesday, March 31st. They issued an “underperform” rating and a $52.00 price target on the stock. Robert W. Baird decreased their price target on Docusign from $75.00 to $55.00 and set a “neutral” rating on the stock in a research note on Wednesday, March 18th. Finally, Royal Bank Of Canada cut their price objective on Docusign from $70.00 to $55.00 and set a “sector perform” rating on the stock in a research report on Wednesday, March 18th. Three equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $61.40.
View Our Latest Research Report on Docusign
Institutional Investors Weigh In On Docusign
Several hedge funds and other institutional investors have recently added to or reduced their stakes in DOCU. Central Pacific Bank Trust Division purchased a new stake in Docusign in the fourth quarter worth $25,000. Modus Advisors LLC purchased a new stake in Docusign in the fourth quarter worth $27,000. Torren Management LLC purchased a new stake in Docusign in the fourth quarter worth $28,000. Aventura Private Wealth LLC purchased a new stake in Docusign in the fourth quarter worth $30,000. Finally, True Wealth Design LLC grew its stake in Docusign by 105.2% in the fourth quarter. True Wealth Design LLC now owns 433 shares of the company’s stock worth $30,000 after purchasing an additional 222 shares during the period. 77.64% of the stock is owned by hedge funds and other institutional investors.
Key Stories Impacting Docusign
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: DocuSign beat Q1 estimates, posting adjusted EPS of $1.09 versus $1.00 expected and revenue of about $830.2 million versus $824.7 million forecast, with sales up 8.7%-9% year over year. DocuSign (DOCU) Q1 Earnings and Revenues Beat Estimates
- Positive Sentiment: The company raised its revenue outlook for fiscal 2027 and said demand is improving for its AI-powered Intelligent Agreement Management platform, which supports the growth story. DocuSign Nudges Revenue Outlook Higher After First-Quarter Profit Rises
- Positive Sentiment: Investors are also encouraged by new AI-related product integrations, including ChatGPT and Codex, which could broaden adoption of DocuSign’s platform. DocuSign (DOCU) Valuation Check After Q1 Beat And New AI Agreement Management Launch
- Neutral Sentiment: DocuSign also highlighted record stock buybacks and continued product launches, but these items appear secondary to the company’s main earnings and guidance narrative. Docusign Inc (DOCU) Q1 2027 Earnings Call Highlights
- Negative Sentiment: Despite the beat, the stock fell in premarket/after-hours trading because guidance did not offer much upside beyond Wall Street expectations, leaving some investors disappointed. DocuSign Tops First-Quarter Forecasts, but Soft Outlook Weighs on Shares (DOCU)
Docusign Company Profile
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Featured Articles
- Five stocks we like better than Docusign
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
